OR WAIT null SECS
September 01, 2016
Existing incentives continue to draw in new drug developers; payers begin to look at competitive markets to drive down drug costs
August 30, 2016
More unusual gyrations as Mylan attempts to quell uprising against its pricing policies
August 29, 2016
Good Neighbor and Health Mart franchises trade top positions
August 25, 2016
Presidential politicking adds momentum to the growing backlash, and not just for Mylan
August 23, 2016
Substantial investments have been made, but beneficial results hard to identify, says ZS Associates
Life sciences marketers contend with a flood of new data sources—and the challenge of integrating them for meaningful results
August 16, 2016
Applying specialty-pharma techniques to a potentially mass-market drug
August 12, 2016
Healthcare research firm calls out the alarmist predictions over PCSK9s and other new drugs
August 01, 2016
Advent joins Thomas Lee Partners in ownership of the clinical, commercial outsourcer